Inventor

Xin LIAN

Inventor

Overview

2→

Patents

2023–2025

Patent span

Human necessities

Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Bprimary

A61BDiagnosis14%

A61KPreparations for medical, dental or toiletry purposes14%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%

C07DHeterocyclic compounds14%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium14%

C07KPeptides14%

G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data14%

PatentTitleYear

12,451,257Electrocardiogram mapping method and system2025 11,767,296Heteroaryl compounds as kinase inhibitor2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023Patents assigned to FUJIAN HAIXI PHARMACEUTICALS CO LTD (1)· patent assignee history

2023–2025Based in CN· patent location history

2025Patents assigned to TIANGONG UNIV (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
FUJIAN HAIXI PHARMACEUTICALS CO LTD	1	2023
TIANGONG UNIV	1	2025

Locations

Location	Patents	Span
CN	2	2023–2025